Tariff Trade War Watch: UK Deal First, China on Watch
When the U.S. announced it had a trade deal with the United Kingdom, stock markets rallied. However, the stock markets peaked from 1 p.m. to 3 p.m. By the end of the day, the buying momentum slowed. What happened?The deal with the U.K. is not finalized. Currently, the U.S. has a trade surplus with the U.K., so the market is concerned about tariffs on net exporting countries. The draft deal will benefit the automotive market. Instead of a 25% tariff on foreign cars imported by the U.S., the U.K. may export up to 100,000 vehicles at a 10% rate.Watch ChinaU.S. trade with China, Canada, and Mexico is significantly bigger. No initial terms are in place yet. Ahead of any discussions, China cut interest rates by a modest 10 basis points to 1.4%. It also lowered the reserve requirement ratio for banks. That would increase liquidity and lighten credit conditions. This should weaken the damage that tariffs are having on China’s economy.Investors may infer that other countries will follow China’s monetary loosening policies. Bank stocks like JPMorgan Chase (JPM), Bank of America (BAC), and Citigroup (C) traded higher. Their share price erased more than the April selloff induced by Liberation Day tariffs.Your TakeawayThe White House is a long way from agreeing to sharply lower tariffs against China, Asian countries, and its neighbors. The global economy remains at risk of a slowdown until the U.S. settles on slashing the proposed tariffs. Until then, look out for the 20+ Year Treasury Bond ETF (TLT) re-testing recent lows.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


